Patrick D. Walsh is Director at ANI PHARMACEUTICALS INC (ANIP). They have made 10 open-market trades across 3 companies since 2020, most recently 2026-05-13.
CIK 0001720568
6 open-market purchases totalling $917K since 2020, against 4 sales. Across 6 scored buys the stock is up 3.9% at ninety days, and 2.2 points behind the S&P over the same stretch.
6 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| ANIP | 38,432 | $2.8M |
| CDMO | 30,000 | $375K |
| LNDC | 40,000 | $350K |
| Total | $3.5M |
Shares reported on the most recent Form 4, priced at the 2026-05-13 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 50% | 83% | 67% |
| Avg Move | +2.0% | +6.0% | +3.9% |
| Alpha | -0.1% | +2.5% | -2.2% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ANIP | SELL | 2026-05-11 | 2026-05-13 | $80.66 | $1.1M | -0.3% | -0.0% | -8.5% |
| ANIP | SELL | 2026-03-03 | 2026-03-03 | $74.23 | $445K | -7.3% | -2.4% | +0.7% |
| ANIP | SELL | 2025-11-13 | 2025-11-17 | $86.88 | $1.5M | +3.2% | +0.2% | -4.0% |
| ANIP | SELL | 2025-08-15 | 2025-08-18 | $89.05 | $801K | +3.5% | +6.6% | -8.3% |
| ANIP | BUY | 2022-03-21 | 2022-03-22 | $27.76 | $139K | +0.9% | +17.7% | -11.9% |
| LNDC | BUY | 2021-04-20 | 2021-04-22 | $11.26 | $113K | -1.0% | +2.1% | +3.8% |
| ANIP | BUY | 2021-03-15 | 2021-03-17 | $32.89 | $132K | -2.2% | +2.4% | +2.5% |
| ANIP | BUY | 2020-11-09 | 2020-11-12 | $25.96 | $130K | +9.1% | +11.9% | +18.9% |
| ANIP | BUY | 2020-08-10 | 2020-08-12 | $30.78 | $308K | -2.2% | -15.6% | -16.9% |
| CDMO | BUY | 2020-03-23 | 2020-03-25 | $3.22 | $97K | +7.4% | +17.2% | +27.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.